Sargramostim [clinicaltrials_resource:618088afb8683a97033308b351a3b5cf]
A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma [clinicaltrials:NCT00000658]A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma [clinicaltrials:NCT00000681]Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma [clinicaltrials:NCT00000689]A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma [clinicaltrials:NCT00000694]Granulocyte-Macrophage Colony-Stimulating Factor and Zidovudine: A Phase I Study of Concurrent Administration in Patients With AIDS and Severe ARC [clinicaltrials:NCT00000711]The Effectiveness of GM-CSF in HIV-Positive Patients Who Are Also Receiving Anti-HIV Therapy [clinicaltrials:NCT00000850]A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients [clinicaltrials:NCT00000896]The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients With AIDS [clinicaltrials:NCT00000989]A Multicenter, Randomized, Placebo-Controlled, Double-Blinded, Phase I Trial to Evaluate the Safety and Immunogenicity of Live Recombinant Canarypox ALVAC-HIV vCP205 Combined With GM-CSF in Healthy, HIV-1 Uninfected Volunteers [clinicaltrials:NCT00001090]A Phase I/II Pilot Study of Simultaneously Administered Rhu GM-CSF ( CHO Cell ) and Azidothymidine ( AZT ) in Patients With Severe HIV Infection and Leukopenia: Pharmacokinetics and Feasibility [clinicaltrials:NCT00002006]A Pilot Trial Evaluating an Alternating Schedule of Recombinant Human GM-CSF and Azidothymidine in Patients With HIV Infection and Leukopenia [clinicaltrials:NCT00002007]An Open Label Phase I Study of Subcutaneously Administered Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia [clinicaltrials:NCT00002008]A Phase I/II Study of Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia [clinicaltrials:NCT00002009]Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis [clinicaltrials:NCT00002070]A Pilot Study to Evaluate the Effects of Subcutaneously Administered Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Pediatric HIV-Infected Patients With Neutropenia Secondary to Azidothymidine [clinicaltrials:NCT00002263]
intervention [clinicaltrials_vocabulary:intervention]
Sargramostim [clinicaltrials_resource:618088afb8683a97033308b351a3b5cf]
Bio2RDF identifier
618088afb8683a97033308b351a3b5cf
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:618088afb8683a97033308b351a3b5cf
intervention name [clinicaltrials_vocabulary:intervention-name]
Sargramostim
identifier
clinicaltrials_resource:618088afb8683a97033308b351a3b5cf
title
Sargramostim
@en
type
label
Sargramostim [clinicaltrials_resource:618088afb8683a97033308b351a3b5cf]
@en